17q12 Recurrent Deletion Syndrome.
Mitchel MW, Moreno-De-Luca D, Myers SM, Levy RV, Turner S, Ledbetter DH, Martin CL.
Mitchel MW, et al.
2016 Dec 8 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
2016 Dec 8 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
PMID: 27929632
Free Books & Documents.
Review.
For individuals with mental health conditions (e.g., ASD, schizophrenia, or bipolar disorder), careful consideration of antipsychotic agents that may lead to weight gain, as this may lead to metabolic syndrome and diabetes mellitus, for which individuals with 17q12 …
For individuals with mental health conditions (e.g., ASD, schizophrenia, or bipolar disorder), careful consideration of antipsychotic agents …